Not applicableStudy completedNCT00900302What this trial is testingOX-40 Protein Expression in the Sentinel Lymph Nodes of Patients With CancerWho this might be right forCancer OHSU Knight Cancer Institute 98
Not applicableLooking for participantsNCT07124000What this trial is testingDESTINY-PANTUMOUR04Who this might be right forAdenocarcinoma (NOS)Anal CancerBladder Cancer+24 more AstraZeneca 100
Not applicableLooking for participantsNCT05463796What this trial is testingInAdvance: Surveillance, Prevention, and Interception in a Population at Risk for CancerWho this might be right forCancer RiskCancer Predisposition SyndromeHereditary Cancer Prediction+28 more Dana-Farber Cancer Institute 5,000
Early research (Phase 1)Study completedNCT00066404What this trial is testingIntrapleural BG00001 in Treating Patients With Malignant Pleural Mesothelioma or Malignant Pleural EffusionsWho this might be right forCancer Abramson Cancer Center at Penn Medicine
Early research (Phase 1)Active Not RecruitingNCT05973487What this trial is testingA Basket Study of Customized Autologous TCR-T Cell Therapies in Patients With Locally Advanced (Unresectable) or Metastatic Solid TumorsWho this might be right forHead and Neck CancerCervical CancerNon-small Cell Carcinoma+18 more TScan Therapeutics, Inc. 840
Not applicableUnknownNCT03896958What this trial is testingThe PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology)Who this might be right forCancer, All TypesCancer of LiverCancer of Stomach+42 more SpeciCare 1,000
Testing effectiveness (Phase 2)Looking for participantsNCT04977453What this trial is testingGI-101 as a Single Agent or in Combination With Pembrolizumab, Lenvatinib or Local Radiotherapy in Advanced Solid TumorsWho this might be right forAdvanced Solid TumorMetastatic Solid TumorNon-small Cell Lung Cancer+11 more GI Innovation, Inc. 430
Testing effectiveness (Phase 2)Looking for participantsNCT05111574What this trial is testingUsing Nivolumab Alone or With Cabozantinib to Prevent Mucosal Melanoma Return After SurgeryWho this might be right forAnal MelanomaBladder MelanomaCervical Melanoma+14 more National Cancer Institute (NCI) 99
Testing effectiveness (Phase 2)Looking for participantsNCT05969860What this trial is testingAt-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced CancerWho this might be right forAdvanced Anal CarcinomaAdvanced Biliary Tract CarcinomaAdvanced Bladder Carcinoma+40 more Mayo Clinic 200
Large-scale testing (Phase 3)Study completedNCT02997553What this trial is testingFluorescence for Sentinel Lymph Node Identification in Cancer SurgeryWho this might be right forBreast CarcinomaHead and Neck CancerMelanoma (Skin)+7 more Institut de Cancérologie de Lorraine 744
Not applicableStudy completedNCT04028479What this trial is testingThe Registry of Oncology Outcomes Associated with Testing and TreatmentWho this might be right forAdenocarcinomaAdenocystic CarcinomaAnal Cancer+73 more Taproot Health 167
Not applicableLooking for participantsNCT06028724What this trial is testingA Study on the Prevalence of Clinically Useful Mutations in Solid Tumor Characterized by Next Generation Sequencing Methods on Liquid Biopsy Analysis (POPCORN)Who this might be right forSolid TumorAdvanced Solid TumorLocally Advanced Solid Tumor+11 more Centro di Riferimento Oncologico - Aviano 782
Early research (Phase 1)Study completedNCT00020579What this trial is testingMS-275 in Treating Patients With Advanced Solid Tumors or LymphomaWho this might be right forCancer National Institutes of Health Clinical Center (CC) 75
Large-scale testing (Phase 3)Study completedNCT00538850What this trial is testingFentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainWho this might be right forCancer INSYS Therapeutics Inc 130
Not applicableStudy completedNCT00897442What this trial is testingCollecting Tumor Samples From Patients With Gynecological TumorsWho this might be right forBorderline Ovarian Clear Cell TumorBorderline Ovarian Serous TumorCervical Adenocarcinoma+83 more Gynecologic Oncology Group 275
Early research (Phase 1)Study completedNCT05578820What this trial is testingSafety, Tolerability and Pharmacokinetics Investigation of Stimotimagene CopolymerplasmidWho this might be right forSarcomaMelanomaSquamous Cell Carcinoma of Head and Neck+5 more Gene Surgery LLC 21
Not applicableLooking for participantsNCT05461430What this trial is testingMass Response of Tumor Cells as a Biomarker for Rapid Therapy Guidance (TraveraRTGx)Who this might be right forPleural Effusion, MalignantAscites, MalignantCarcinoma+29 more Travera Inc 200
Testing effectiveness (Phase 2)Active Not RecruitingNCT02978625What this trial is testingTalimogene Laherparepvec and Nivolumab in Treating Patients With Refractory Lymphomas or Advanced or Refractory Non-melanoma Skin CancersWho this might be right forAnaplastic Large Cell Lymphoma, ALK-NegativeAnaplastic Large Cell Lymphoma, ALK-PositiveApocrine Carcinoma+36 more National Cancer Institute (NCI) 68
Testing effectiveness (Phase 2)Looking for participantsNCT05592626What this trial is testingA Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid TumorsWho this might be right forAdvanced Solid TumorsGenital Neoplasm, FemaleUrogenital Neoplasms+9 more Marengo Therapeutics, Inc. 365
Not applicableStudy completedNCT01526486What this trial is testingVideoscopic Versus Open Inguinal Lymphadenectomy for CancerWho this might be right forMelanomaMerkel Cell CarcinomaSquamous Cell Carcinoma+8 more Emory University 29